🚦Reclassifying Risk in the Diabetic Foot: Pulse Volume Recordings May Show Promise—And Ordinal Power
In the ever-complex world of diabetic foot syndrome (DFS), detecting peripheral arterial disease (PAD) is as much about nuance as it is about numbers. A newly published study by Nützel et al. in Biomedicines brings us one step closer to clinical clarity by evaluating the diagnostic value of forefoot-level pulse volume recordings (PVRs)—both semiquantitative and quantitative—as tools to detect PAD in patients with DFS .
And here’s the twist: this may fit beautifully into the WIfI (Wound, Ischemia, foot Infection) classification—not just as another data point, but as an ordinal input.
🔍 The Study
This retrospective analysis examined 90 limbs in 70 patients with diabetic foot ulcers who underwent both digital subtraction angiography and segmental PVRs within 30 days. Many had medial arterial calcification (MAC)—a frequent foe of ABI reliability—and over half had ABI ≥ 1.3 .
Forefoot-level PVRs were assessed:
- Semiquantitatively: by waveform morphology (normal, mildly abnormal, severely abnormal, non-pulsatile)
- Quantitatively: via Upstroke Time (UST), Upstroke Ratio (USR), and Maximum Systolic Amplitude (MSA)
In essence, the waveform became a surrogate language for vascular health.
📊 The Ordinal Opportunity: Visual PVR Morphology
Figure 2 from the manuscript (and the accompanying illustration above) shows the visual semiquantitative grading scale, from normal to non-pulsatile. This 4-tiered system—normal, mildly abnormal, severely abnormal, non-pulsatile—aligns closely with the logic of WIfI’s ordinal ischemia grading (0 to 3). Each level of waveform degradation corresponded to more severe PAD per the GLASS classification .
- Normal PVRs aligned with GLASS 0–1
- Mildly abnormal PVRs had 50% inframalleolar compromise
- Severely abnormal PVRs trended toward GLASS stage 2–3
- Non-pulsatile PVRs reflected critical limb-threatening ischemia (CLTI)
The ordinal structure of these categories may allow seamless integration into the WIfI ischemia score, especially when traditional hemodynamic metrics like ABI or toe pressure are unavailable or unreliable.
🧪 Quantitative Metrics: MSA Outperforms
Quantitatively, MSA was the strongest predictor of PAD:
- A cut-off of 0.27 mmHg yielded 72.2% sensitivity and 77.1% specificity for detecting severe PAD (GLASS ≥ 2) .
- ROC curves showed MSA outperformed UST and USR across subgroups, including those with:
- Elevated ABI (MAC)
- Foot infection (Armstrong B/D limbs)
Though limited in detecting inframalleolar disease (sensitivity ~63%), MSA values improved significantly post-revascularization, reflecting perfusion responsiveness.
🧩 Clinical Implications: Fitting PVR into WIfI
The WIfI ischemia score has traditionally relied on ABI, toe pressure, or TcPO₂. But in MAC-heavy populations—like this one, where over 50% had ABI ≥ 1.3—those tools may falter.
PVRs provide:
- Ordinal semiquantitative data that aligns with WIfI staging logic
- Quantitative vascular metrics (e.g., MSA) responsive to therapy
- Ease of acquisition, as these recordings can be obtained by trained staff, even in busy clinics
🧠 Final Thought: A 50-Year-Old Tool Gets a Modern Makeover
Although pulse volume recording dates back to the 1970s, this study reframes it for today’s diabetic limb-at-risk. By showing its correlation with angiographic PAD severity and its resilience in the presence of MAC, the authors open the door for PVRs to move from archival curiosity to WIfI-era clinical asset.
📄 Full Citation:
Nützel A, Reik LJU, Hamberger M, et al. “Segmental Pulse Volume Recordings at the Forefoot Level as a Valuable Diagnostic Tool for Detection of Peripheral Arterial Disease in the Diabetic Foot Syndrome.” Biomedicines. 2025;13(6):1281. https://doi.org/10.3390/biomedicines13061281
Leave a Reply